MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
MAIA Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MAIA Biotechnology's enterprise value was $62.64M on Nov 11, 2026, against $40.65M a year earlier. Over the last 4 years it ranged from $7.66M to $89.49M, with a median of $46.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $62.64M | +18.8% |
| 2025 | Dec 31, 2025 | $52.71M | +11.1% |
| 2024 | Dec 31, 2024 | $47.45M | +374.7% |
| 2023 | Dec 29, 2023 | $10.00M | -59.0% |
| 2022 | Dec 30, 2022 | $24.36M | – |
See a number that looks wrong?